Ekso Bionics Holdings, Inc. (EKSO)

Market Cap	6.35M
Revenue (ttm)	17.54M
Net Income (ttm)	-10.79M
Shares Out	1.94M
EPS (ttm)	-7.31
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	36,718
Open	3.480
Previous Close	3.490
Day's Range	3.270 - 3.480
52-Week Range	2.730 - 22.950
Beta	0.81
Analysts	Strong Buy
Price Target	37.50 (+1,043.29%)
Earnings Date	Jul 28, 2025

About EKSO

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therapy, an adjustable and lower-limb powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; Ekso Nomad, a power knee ankle foot ort...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2005
• Employees: 66
• Stock Exchange: NASDAQ
• Ticker Symbol: EKSO
• Website: https://www.eksobionics.com

Financial Performance

In 2024, Ekso Bionics Holdings's revenue was $17.93 million, a decrease of -1.94% compared to the previous year's $18.28 million. Losses were -$11.33 million, -25.45% less than in 2023.

Analyst Summary

According to 2 analysts, the average rating for EKSO stock is "Strong Buy." The 12-month stock price target is $37.5, which is an increase of 1,043.29% from the latest price.

Price Target

$37.5

(1,043.29% upside)

Analyst Consensus: Strong Buy